BUENA, N.J., March 31, 2014 /PRNewswire/ -- IGI
Laboratories, Inc. (NYSE Amex: IG), a New
Jersey based topical generic pharmaceutical company, will be
presenting at the Needham & Company's 13th Annual Healthcare
Conference. The Conference will take place on April 8-9, 2014 at the Westin Grand Central Hotel
in New York City.
Jason Grenfell-Gardner, CEO and
President and Jenniffer Collins,
Chief Financial Officer of IGI Laboratories, Inc. will present on
Tuesday April 8,
2014 at 3:40 p.m. ET. Investors attending the
conferences who wish to meet with Mr. Grenfell-Gardner and Mrs.
Collins for a one-on-one meeting should contact their Needham &
Company representative directly.
The presentation will be webcast and will be accessible online
on the investors section of the Company's website at
http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical
company. We develop and manufacture topical formulations for
the pharmaceutical, OTC, and cosmetic markets. Our mission is to be
a leading player in the generic topical prescription drug
market.
Logo -
http://photos.prnewswire.com/prnh/20130827/MM70487LOGO
SOURCE IGI Laboratories, Inc.